Integrative Genomic and Transcriptomic Analysis Reveals Hypothesis-Generating Candidate Genes for Nephrolithiasis Susceptibility in Primary Hyperoxaluria.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος:	Integrative Genomic and Transcriptomic Analysis Reveals Hypothesis-Generating Candidate Genes for Nephrolithiasis Susceptibility in Primary Hyperoxaluria.
Συγγραφείς:	Li Y; Nephrology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Li Y; Department of Kidney Transplantation, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Zhang J; Department of Kidney Transplantation, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Lin X; Nephrology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Lv J; Nephrology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Yang X; Nephrology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Han J; Nephrology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Lu W; Nephrology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Wang T; Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Πηγή:	Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2026 Oct; Vol. 31 (10), pp. e70279.
Τύπος έκδοσης:	Journal Article
Γλώσσα:	English
Στοιχεία περιοδικού:	Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE
Imprint Name(s):	Original Publication: Carlton, Vic., Australia : Blackwell Science
Ιατρικοί όροι (MeSH):	Hyperoxaluria, Primary/genetics , Hyperoxaluria, Primary/complications , Nephrolithiasis/genetics , Transcriptome, Genomics/methods ; Humans ; Animals ; Genetic Predisposition to Disease ; Female ; Male ; Exome Sequencing ; Mutation ; Phenotype ; Gene Expression Profiling ; Rats ; Disease Models, Animal ; Child ; Child, Preschool ; DNA Mutational Analysis ; Adolescent ; Transaminases
Περίληψη:	Aim: Primary hyperoxaluria (PH) represents a rare genetic disorder characterised by incompletely elucidated causative genes and limited therapeutic options. This study aims to identify PH-associated genetic variants and potential drug targets. Methods: We performed exon sequencing of eight PH patients to find PH-related mutant genes, and used the PH rat model to explore differentially expressed genes related to PH. Key core genes related to PH are identified through functional enrichment analysis and protein interaction analysis. Results: Whole-exome sequencing of eight patients with a clinical diagnosis of Primary Hyperoxaluria Type 1 (PH1) identified biallelic pathogenic or likely pathogenic AGXT variants in five individuals. One patient was partially confirmed, and two patients were clinically confirmed only. Additional rare variants were detected across AGXT, GRHPR, HOGA1, PEX1 and OxGR1; variants in intronic regions were retained only if predicted to affect splicing. In total, two patients harboured ≥ 20 rare variants in AGXT, and four patients had > 10 rare variants in PEX1. Across five candidate genes, 548 shared variant-bearing genes were enriched in cytoskeletal organization and cell adhesion. SNV analysis showed frameshift insertions and deletions as the most frequent mutation types, and AGAP3 and SON were the most heavily mutated, implicating NK cell regulation. Germline rare variant load-defined as the total number of rare variants (MAF < 1%) per patient identified by WES-showed a negative correlation with serum creatinine, blood urea nitrogen, phosphorus and PTH levels, and was elevated in patients from consanguineous families, suggesting that a higher degree of genomic homozygosity may modify disease phenotype. A total of 678 differentially expressed genes were found in differential expression analysis of the PH model. These genes were mainly related to mitochondrial function. Through cross-analysis, a total of 347 genes were found. These genes exhibited both differential expression in the rat model and rare germline variants in patient WES data. Through module screening, two key modules were found, which were mainly related to cell-cycle/mitotic processes and immune response. Comparative analysis of patients with and without nephrolithiasis identified 22 genes with nominally differential distribution; this finding is exploratory and requires validation in larger cohorts. Conclusion: This study provides new insights into PH pathogenesis through integrative WES and transcriptomic analysis, identifying hypothesis-generating candidate genes potentially linked to nephrolithiasis susceptibility in this small cohort that warrant further functional validation in larger, independent populations. (© 2026 Asian Pacific Society of Nephrology.)
References:	R. J. A. Wanders, J. W. Groothoff, L. J. Deesker, E. Salido, and S. F. Garrelfs, “Human Glyoxylate Metabolism Revisited: New Insights Pointing to Multi‐Organ Involvement With Implications for siRNA‐Based Therapies in Primary Hyperoxaluria,” Journal of Inherited Metabolic Disease 48, no. 1 (2025): e12817. X. Zhu, W. W. Cheung, A. Zhang, and G. Ding, “Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status,” Kidney Disease 10, no. 4 (2024): 313–326. Y. Zheng, Q. Li, and S. Liang, “Infant Primary Hyperoxaluria Type 1: A Case Report and Literature Review,” Zhong Nan Da Xue Xue Bao. Yi Xue Ban 49, no. 6 (2024): 856–862. Y. Song, C. Zhao, and D. Li, “Research Progress on Renal Calculus Associate With Inborn Error of Metabolism,” Zhejiang Da Xue Xue Bao. Yi Xue Ban 52, no. 2 (2023): 169–177. G. Mandrile, B. Beck, C. Acquaviva, et al., “Genetic Assessment in Primary Hyperoxaluria: Why It Matters,” Pediatric Nephrology 38, no. 3 (2023): 625–634. N. A. Soliman and S. Mabrouk, “Primary Hyperoxaluria Type 1 in Developing Countries: Novel Challenges in a New Therapeutic Era,” Clinical Kidney Journal 15, no. 1 (2022): i33–i36. J. Bacchetta and J. C. Lieske, “Primary Hyperoxaluria Type 1: Novel Therapies at a Glance,” Clinical Kidney Journal 15, no. 1 (2022): i17–i22. A. Abid, A. Raza, T. Aziz, and S. Khaliq, “HOGA1 Gene Pathogenic Variants in Primary Hyperoxaluria Type III: Spectrum of Pathogenic Sequence Variants, and Phenotypic Association,” Human Mutation 43, no. 12 (2022): 1757–1779. X. Liao, Y. J. Li, F. Zhong, et al., “Clinical Analysis of Seven Cases With Primary Hyperoxaluria Type 1 in Children,” Zhonghua Er Ke Za Zhi 58, no. 2 (2020): 129–134. R. D. Bulow and P. Boor, “Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold,” Journal of Histochemistry and Cytochemistry 67, no. 9 (2019): 643–661. G. H. Ran, Y. Q. Lin, L. Tian, et al., “Natural Killer Cell Homing and Trafficking in Tissues and Tumors: From Biology to Application,” Signal Transduction and Targeted Therapy 7, no. 1 (2022): 205. J. E. Turner, C. Rickassel, H. Healy, and A. J. Kassianos, “Natural Killer Cells in Kidney Health and Disease,” Frontiers in Immunology 10 (2019): 587. C. Cantoni, S. Granata, M. Bruschi, G. M. Spaggiari, G. Candiano, and G. Zaza, “Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury,” Frontiers in Immunology 11 (2020): 1484. M. Kaur, R. Varanasi, D. Nayak, S. Tandon, V. Agrawal, and C. Tandon, “Molecular Insights Into Cell Signaling Pathways in Kidney Stone Formation,” Urolithiasis 53, no. 1 (2025): 30. S. Joshi and S. R. Khan, “Opportunities for Future Therapeutic Interventions for Hyperoxaluria: Targeting Oxidative Stress,” Expert Opinion on Therapeutic Targets 23, no. 5 (2019): 379–391. J. A. Fernandez‐Higuero, I. Betancor‐Fernandez, N. Mesa‐Torres, A. Muga, E. Salido, and A. L. Pey, “Structural and Functional Insights on the Roles of Molecular Chaperones in the Mistargeting and Aggregation Phenotypes Associated With Primary Hyperoxaluria Type I,” Advances in Protein Chemistry and Structural Biology 114 (2019): 119–152. R. Shen, X. Zhao, L. He, et al., “Upregulation of RIN3 Induces Endosomal Dysfunction in Alzheimer's Disease,” Translational Neurodegeneration 9, no. 1 (2020): 26. A. C. Vagiona, P. Mier, and M. A. Andrade‐Navarro, “Unraveling Cooperative and Competitive Interactions Within Protein Triplets in the Human Interactome,” Scientific Reports 15, no. 1 (2025): 32548. V. Delague, A. Jacquier, T. Hamadouche, et al., “Mutations in FGD4 Encoding the Rho GDP/GTP Exchange Factor FRABIN Cause Autosomal Recessive Charcot‐Marie‐Tooth Type 4H,” American Journal of Human Genetics 81, no. 1 (2007): 1–16. E. Salido, A. L. Pey, R. Rodriguez, and V. Lorenzo, “Primary Hyperoxalurias: Disorders of Glyoxylate Detoxification,” Biochimica et Biophysica Acta 1822, no. 9 (2012): 1453–1464. B. Hoppe, “An Update on Primary Hyperoxaluria,” Nature Reviews. Nephrology 8, no. 8 (2012): 467–475. B. Cellini, E. Oppici, A. Paiardini, and R. Montioli, “Molecular Insights Into Primary Hyperoxaluria Type 1 Pathogenesis,” Frontiers in Bioscience 17, no. 2 (2012): 621–634.
Grant Information:	2024JC-YBMS-672 Institutional Foundation of Natural Science Foundation of Shaanxi Province; 2021ZYTS-20 Institutional Foundation of The First Affiliated Hospital of Xi'an Jiaotong University; XJTU1AF-CRF-2022-041 The Rare Kidney Disease Registry Study of the First Affiliated Hospital of Xi'an Jiaotong University (FAHXJTURKReg)
Contributed Indexing:	Keywords: AGXT; RIN3; primary hyperoxaluria; whole‐exome sequencing
Substance Nomenclature:	EC 2.6.1.44 (Alanine-glyoxylate transaminase) EC 2.6.1.- (Transaminases)
SCR Disease Name:	Primary hyperoxaluria type 1
Entry Date(s):	Date Created: 20260923 Date Completed: 20260923 Latest Revision: 20260923
Update Code:	20260923
DOI:	10.1111/nep.70279
PMID:	42775502
Βάση Δεδομένων:	MEDLINE

Full Text Finder

Περιγραφή
ISSN:	1440-1797
DOI:	10.1111/nep.70279